izpis_h1_title_alt

Single cell RNA sequencing in autoimmune inflammatory rheumatic diseases : current applications, challenges and a step toward precision medicine
ID Kuret, Tadeja (Avtor), ID Sodin-Šemrl, Snežna (Avtor), ID Leskošek, Branimir (Avtor), ID Ferk, Polonca (Avtor)

.pdfPDF - Predstavitvena datoteka, prenos (800,05 KB)
MD5: 0CAF3F8CFE9F5EB30B2CE29FA535874B
URLURL - Izvorni URL, za dostop obiščite https://www.frontiersin.org/articles/10.3389/fmed.2021.822804/full Povezava se odpre v novem oknu

Izvleček
Single cell RNA sequencing (scRNA-seq) represents a new large scale and high throughput technique allowing analysis of the whole transcriptome at the resolution of an individual cell. It has emerged as an imperative method in life science research, uncovering complex cellular networks and providing indices that will eventually lead to the development of more targeted and personalized therapies. The importance of scRNA-seq has been particularly highlighted through the analysis of complex biological systems, in which cellular heterogeneity is a key aspect, such as the immune system. Autoimmune inflammatory rheumatic diseases represent a group of disorders, associated with a dysregulated immune system and high patient heterogeneity in both pathophysiological and clinical aspects. This complicates the complete understanding of underlying pathological mechanisms, associated with limited therapeutic options available and their long-term inefficiency and even toxicity. There is an unmet need to investigate, in depth, the cellular and molecular mechanisms driving the pathogenesis of rheumatic diseases and drug resistance, identify novel therapeutic targets, as well as make a step forward in using stratified and informed therapeutic decisions, which could now be achieved with the use of single cell approaches. This review summarizes the current use of scRNA-seq in studying different rheumatic diseases, based on recent findings from published in vitro, in vivo, and clinical studies, as well as discusses the potential implementation of scRNA-seq in the development of precision medicine in rheumatology.

Jezik:Angleški jezik
Ključne besede:rheumatoid arthritis, systemic lupus erythematosus, RNA sequencing, single cell, systemic sclerosis, precision medicine
Vrsta gradiva:Članek v reviji
Tipologija:1.02 - Pregledni znanstveni članek
Organizacija:MF - Medicinska fakulteta
Status publikacije:Objavljeno
Različica publikacije:Objavljena publikacija
Leto izida:2022
Št. strani:18 str.
Številčenje:Vol. 8, art. 822804
PID:20.500.12556/RUL-145362 Povezava se odpre v novem oknu
UDK:616-002
ISSN pri članku:2296-858X
DOI:10.3389/fmed.2021.822804 Povezava se odpre v novem oknu
COBISS.SI-ID:93835779 Povezava se odpre v novem oknu
Datum objave v RUL:19.04.2023
Število ogledov:414
Število prenosov:52
Metapodatki:XML RDF-CHPDL DC-XML DC-RDF
:
Kopiraj citat
Objavi na:Bookmark and Share

Gradivo je del revije

Naslov:Frontiers in medicine
Skrajšan naslov:Front. med.
Založnik:Frontiers Media
ISSN:2296-858X
COBISS.SI-ID:523095065 Povezava se odpre v novem oknu

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.

Sekundarni jezik

Jezik:Slovenski jezik
Ključne besede:revmatoidni artritis, sistemski eritematozni lupus, sekvenciranje RNA

Projekti

Financer:ARRS - Agencija za raziskovalno dejavnost Republike Slovenije
Številka projekta:P3-0154
Naslov:Metodologija za analizo podatkov v medicini

Podobna dela

Podobna dela v RUL:
Podobna dela v drugih slovenskih zbirkah:

Nazaj